AN2 Therapeutics (ANTX)

• Market cap: $31.2M
• 1 day: 0.88%
• 5 days: -5%
• 1 month: 1.79%
• 3 months: -11.63%
• 6 months: 3.64%
• Year to date: -17.99%
• 1 year: -12.98%
• 5 years: -92.6%
• 10 years: -92.6%
• Sector: Healthcare
• Industry: Biotechnology

About: AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Employees: 36